شیرین‌ دارو

دشیری | Stocks - Iran Fara Bourse (IFB)

داروهای شیمیایی و گیاهی

Sector:

Market Type:

Status:

Last Price: - 0.00

Close Price: -

	2026/06/16 Fiscal Year 2026/03/2012 Month	2025/04/30 Fiscal Year 2025/03/2012 Month	2024/07/14 Fiscal Year 2024/03/1912 Month
Net Profit to Sales	61.38	54.15	64.11
Gross Profit to Sales	61.47	54.38	64.16
Operating Margin	61.14	47.95	63.44
Gross Profit to Sales	55.09	43.82	36.57
Net Profit to Gross Profit	111.43	123.58	175.29
Return on Assets (ROA)	52.38	47.61	31.52
Return on Capital (%)	5,085.38	3,198.05	2,054.99
Return on Equity (ROE)	84.48	71.8	76.22
Working Capital Return	94.4	81.87	76.48
Fixed Asset Return	508.21	392.38	1,181.37
Loan Benefit Assessment	1.61	1.51	2.42
Current Ratio	2.65	2.98	1.74
Quick Ratio	1.56	1.09	0.98
Liquidity Ratio	0.2	0.17	0.16
Net Working Capital	2,693,559	1,953,020	1,343,415
Current Assets Ratio	0.89	0.87	0.97
Inventory Turnover	356.53	356	343.6
Receivables Collection Period	196.27	108.49	337.76
Inventory to Working Capital	0.66	0.95	1.02
Working Capital Turnover	1.54	1.51	1.19
Fixed Asset Turnover	8.28	7.25	18.43
Total Asset Turnover	0.85	0.88	0.49
Debt Ratio	0.38	0.34	0.59
Debt to Equity	0.61	0.51	1.42
Long-Term Debt to Equity	0.07	0.07	0.07
Current Debt to Equity	0.54	0.44	1.35
Equity Ratio	62.01	66.31	41.35
Debt Coverage Ratio	2.39	2.79	0.92

At a Glance